Abstract Background: The clinical significance of ER-low tumors compared with ER-0 tumors in HER2-negative breast cancer remains poorly defined, particularly regarding response to neoadjuvant chemotherapy and survival outcomes. This study aimed to compare the clinical characteristics, treatment response, and survival outcomes between ER-low and ER-0 tumors in a real-world multicenter cohort.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Songping
Contact Songping, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack